Michael Keating, MD
ALL Specialist
43 years treating Acute Lymphocytic Leukemia
%20(1)-min_0bfd4a6c-14c4-4042-ae71-7bbba711a16e.jpg?alt=media&token=70b523f0-5fcc-4d33-99db-0850b88dabe2)
Clinical Expertise
Leukemia, Acute Lymphoblastic (ALL)
About
Over the last 30 years, he has been involved in clinical research in chronic lymphocytic leukemia (CLL). During this time the complete remission rate has risen dramatically from approximately 5% to 50 – 60%. This is associated with improvements in developmental therapeutic programs but also a dramatic improvement in the understanding of the biology and prognostic factors of CLL. CLL is a disease of the elderly and the characterization of other cancers in survivors of CLL is vitally important. Understanding of this comparison between incidence and characteristics of other cancers in CLL survivors is vitally important in its own right but must be integrated into clinical understanding of the disease. He is totally committed to providing clinical and intellectual resources at his disposal to support the program.
Location
University Of Texas At Austin - Dell Medical School: 1501 Red River St, Austin, TX 78712, USA
Get the latest thought leadership on Acute Lymphocytic Leukemia delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Acute Lymphocytic Leukemia Newsletter" for Acute Lymphocytic Leukemia news, life with Acute Lymphocytic Leukemia stories, Acute Lymphocytic Leukemia clinical trials, Acute Lymphocytic Leukemia 101 articles and events with Acute Lymphocytic Leukemia experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2023 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811